ShareValue scores for ZIMLAB.NSE: Valuation 66, Quality 45, Growth 22, Health 43.

ZIMLAB.NSE
NSE

Zim Laboratories Limited

₹119.85(+4.71%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
66
Fair Value
Price vs Value
Quality
45
Moderate
Business Strength
Growth
22
Weak
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
92
Bullish
Price Trend

Company Details

About

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026